February 2022
Dr. Lucas Salas M.D., MPH, Ph.D., and QBS Ph.D. student Ze Zhang, published their novel immune-profiling method using DNA from blood in Nature Communications. Their work is picked up by the online news services GenomeWeb and Medical Xpress.
September 2021
Graduating Geisel School of Medicine M.D., Dr. Nasim Azizgolshani, published her lead author work on pediatric central nervous system tumor epigenetic profiles in Clinical Epigenetics.
January 2021
New NCI R01 grant that aims to predict response to immunotherapy in patients with head and neck cancers. Includes collaborators at Brown, Dana-Farber Cancer Institute, University of Kansas, and Dartmouth Hitchcock.
NIH RePORTER: DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
December 2016
PEMM PhD student Kevin Johnson's Nature Communications paper on 5-hydroxymethylcytosine in glioblastoma is picked up by the NIH Director's blog.
Precision Oncology: Epigenetic Patterns Predict Glioblastoma Outcomes